Cannae (CNNE) Financials

Cannae logo
$17.51 +0.46 (+2.69%)
Closing price 03:59 PM Eastern
Extended Trading
$17.51 +0.00 (+0.01%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Cannae

Annual Income Statements for Cannae

This table shows Cannae's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-23 -12 109 28 77 1,786 -287 -428 -627 -609 -1,026
Consolidated Net Income / (Loss)
-7.30 -12 93 -11 47 1,760 -286 -430 -324 -310 -525
Net Income / (Loss) Continuing Operations
-10 -14 -57 -8.50 99 1,760 -286 -430 -306 -288 -427
Total Pre-Tax Income
-3.80 5.20 -74 23 238 2,182 -433 -336 -200 -252 -191
Total Operating Income
-12 -2.20 -78 -146 -118 -189 -134 -145 -119 -104 -120
Total Gross Profit
134 126 166 156 157 61 45 31 43 2.90 -8.20
Total Revenue
1,415 1,178 1,157 1,148 1,070 586 742 662 570 453 424
Operating Revenue
1,412 1,178 1,157 1,148 1,070 586 742 662 570 453 424
Total Cost of Revenue
1,281 1,052 991 991 913 524 698 631 527 450 432
Operating Cost of Revenue
1,281 1,052 991 991 913 524 698 631 527 450 432
Total Operating Expenses
146 128 243 302 275 250 178 176 162 107 111
Selling, General & Admin Expense
96 84 101 92 133 117 152 153 143 93 100
Depreciation Expense
50 45 46 46 41 31 27 23 19 13 12
Total Other Income / (Expense), net
8.30 7.40 3.20 168 356 2,370 -300 -191 -82 -148 -71
Interest Expense
5.50 5.20 7.00 4.70 18 9.00 9.80 12 18 12 12
Interest & Investment Income
2.00 3.30 5.30 6.30 16 17 21 2.50 14 4.60 10
Other Income / (Expense), net
12 9.30 4.90 167 358 2,362 -311 -181 -77 -141 -69
Income Tax Expense
-20 -10 -14 15 24 481 -74 -90 -72 3.30 13
Other Gains / (Losses), net
-26 -30 3.40 -16 -115 59 73 -184 -177 -33 -224
Net Income / (Loss) Discontinued Operations
2.80 2.00 149 -2.10 -52 - - - -18 -22 -98
Net Income / (Loss) Attributable to Noncontrolling Interest
16 0.50 -16 -38 -31 -26 0.60 -1.50 -11 -5.50 -12
Basic Earnings per Share
($0.32) ($0.18) $1.54 $0.39 $1.07 $20.84 ($3.19) ($5.25) ($4.27) ($4.73) ($9.08)
Weighted Average Basic Shares Outstanding
70.60M 70.60M 70.60M 71.20M 72.20M 85.70M 90.10M 81.60M 73.40M 64.40M 56.50M
Diluted Earnings per Share
($0.32) ($0.18) $1.54 $0.39 $1.07 $20.79 ($3.19) ($5.25) ($4.27) ($4.73) ($9.08)
Weighted Average Diluted Shares Outstanding
70.60M 70.60M 70.60M 71.30M 72.40M 85.90M 90.10M 81.60M 73.40M 64.40M 56.50M
Weighted Average Basic & Diluted Shares Outstanding
- 68.90M 70.60M 70.80M 79.52M 91.65M 86.49M 76.26M 72.48M 62.79M 46.32M
Cash Dividends to Common per Share
- - - - - - - - - - $0.54

Quarterly Income Statements for Cannae

This table shows Cannae's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-90 -155 -14 -46 -226 -478 -137 -606 -64 75 -40
Consolidated Net Income / (Loss)
-92 -155 -18 -46 -115 -241 -71 -99 -36 28 -25
Net Income / (Loss) Continuing Operations
-75 -149 -16 -46 -39 -230 -54 -99 -36 28 -8.60
Total Pre-Tax Income
-36 -170 2.90 -48 -17 -136 -0.10 -32 -30 28 4.30
Total Operating Income
-41 -23 -18 -22 -21 -61 -7.40 -24 -22 -57 -26
Total Gross Profit
-6.70 6.70 2.80 0.10 -2.00 -17 8.00 4.40 1.10 4.00 0.70
Total Revenue
111 118 114 110 103 110 81 103 96 102 68
Operating Revenue
111 118 114 110 103 110 81 103 96 102 68
Total Cost of Revenue
117 111 111 110 105 127 73 99 95 98 67
Operating Cost of Revenue
117 111 111 110 105 127 73 99 95 98 67
Total Operating Expenses
34 30 21 22 19 44 15 29 23 61 27
Selling, General & Admin Expense
31 26 18 19 16 41 13 26 21 26 9.60
Depreciation Expense
3.30 3.40 3.30 3.30 3.10 3.00 2.20 2.90 2.60 2.40 1.30
Impairment Charge
- - - - - 0.00 0.00 - - 32 16
Total Other Income / (Expense), net
4.40 -147 21 -26 4.80 -75 7.30 -7.70 -7.40 85 31
Interest Expense
2.60 2.00 2.90 4.10 3.80 3.30 3.00 1.50 2.30 1.20 0.90
Interest & Investment Income
2.10 0.70 0.80 1.00 1.40 4.80 1.80 2.00 2.10 3.50 1.30
Other Income / (Expense), net
4.90 -146 23 -23 7.20 -76 8.50 -8.20 -7.20 83 30
Income Tax Expense
57 -36 -6.40 -14 20 -1.80 -3.80 -1.60 0.50 1.70 1.50
Other Gains / (Losses), net
18 -15 -25 -12 -1.90 -96 -58 -68 -5.80 1.80 -11
Net Income / (Loss) Discontinued Operations
-17 -6.10 -1.50 - -76 -11 -17 - 0.00 0.00 -16
Net Income / (Loss) Attributable to Noncontrolling Interest
-1.90 0.00 -3.90 0.30 -2.00 -1.70 -2.40 -5.60 -3.70 -9.10 -4.40
Basic Earnings per Share
($1.27) ($2.49) ($0.22) ($0.75) ($1.81) ($3.93) ($1.25) ($2.09) ($0.70) $0.86 ($0.48)
Weighted Average Basic Shares Outstanding
70.80M 62.20M 62.40M 64.40M 62.30M 60.80M 54.70M 56.50M 45.90M 43.50M 42.30M
Diluted Earnings per Share
($1.27) ($2.49) ($0.22) ($0.75) ($1.81) ($3.93) ($1.25) ($2.09) ($0.70) $0.86 ($0.48)
Weighted Average Diluted Shares Outstanding
70.90M 62.20M 62.40M 64.40M 62.30M 60.80M 54.70M 56.50M 45.90M 43.60M 42.30M
Weighted Average Basic & Diluted Shares Outstanding
62.77M 62.73M 62.74M 62.79M 62.82M 56.01M 49.29M 46.32M 43.94M 43.37M 39.23M

Annual Cash Flow Statements for Cannae

This table details how cash moves in and out of Cannae's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
72 -129 99 77 211 191 -639 162 -142 25 51
Net Cash From Operating Activities
11 60 -91 -23 -84 -114 -176 -205 -88 -90 -18
Net Cash From Continuing Operating Activities
11 60 -91 -23 -84 -114 -176 -205 -88 -90 -18
Net Income / (Loss) Continuing Operations
-7.30 -12 93 -11 47 1,760 -286 -430 -324 -310 -525
Consolidated Net Income / (Loss)
-7.30 -12 93 -11 47 1,760 -286 -430 -324 -310 -525
Depreciation Expense
66 63 58 61 55 31 26 23 19 13 12
Amortization Expense
- - - 0.00 39 25 23 22 19 15 15
Non-Cash Adjustments To Reconcile Net Income
45 37 -286 -79 -135 -2,270 263 416 323 221 446
Changes in Operating Assets and Liabilities, net
-92 -27 45 5.10 -89 341 -201 -236 -125 -28 34
Net Cash From Investing Activities
273 -168 92 187 -24 -74 -272 521 53 298 518
Net Cash From Continuing Investing Activities
273 -168 92 187 -24 -74 -272 521 53 298 518
Purchase of Property, Plant & Equipment
-55 -50 -40 -16 -28 -22 -14 -14 -10 -7.00 -10
Purchase of Investments
-34 -46 -5.60 -42 0.00 -325 -1,005 -178 -331 -266 -162
Sale of Property, Plant & Equipment
82 0.00 0.00 4.90 21 4.40 10 9.20 7.30 6.80 1.70
Sale and/or Maturity of Investments
316 78 34 26 37 787 774 350 387 375 59
Other Investing Activities, net
-0.60 -0.70 1.40 56 70 -527 -102 354 0.00 190 630
Net Cash From Financing Activities
-213 -21 98 -86 319 379 -190 -154 -107 -183 -450
Net Cash From Continuing Financing Activities
-213 -21 98 -86 319 379 -190 -154 -107 -183 -450
Repayment of Debt
-31 -45 -36 -124 -291 -109 -236 -225 -58 -29 -143
Repurchase of Common Equity
- - 0.00 0.00 -4.90 -14 -160 -230 -113 -231 -320
Payment of Dividends
-28 -0.70 -0.40 -0.10 -0.90 -0.80 -0.20 -8.10 -0.70 -23 -31
Issuance of Debt
132 77 84 34 367 45 207 309 66 104 45
Other Financing Activities, net
-286 -52 50 -0.20 12 -0.80 -0.20 0.00 -0.20 -3.60 -1.60

Quarterly Cash Flow Statements for Cannae

This table details how cash moves in and out of Cannae's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
132 -193 115 -29 -5.30 -60 167 -52 -46 -64 40
Net Cash From Operating Activities
-36 -10 -32 -12 9.10 -22 -22 16 -21 -5.20 29
Net Cash From Continuing Operating Activities
-36 -10 -32 -12 9.10 -22 -22 16 -21 -5.20 29
Net Income / (Loss) Continuing Operations
-92 -155 -18 -46 -115 -241 -71 -99 -36 28 -25
Consolidated Net Income / (Loss)
-92 -155 -18 -46 -115 -241 -71 -99 -36 28 -25
Depreciation Expense
3.30 3.40 3.30 3.30 3.10 3.00 2.90 2.90 2.60 2.40 0.30
Amortization Expense
3.40 3.30 3.40 4.40 3.40 3.40 3.50 4.80 3.20 2.70 0.30
Non-Cash Adjustments To Reconcile Net Income
-1.30 173 6.90 43 77 195 62 112 13 -38 11
Changes in Operating Assets and Liabilities, net
50 -35 -28 -17 41 18 -19 -5.50 -3.90 -0.70 42
Net Cash From Investing Activities
195 58 55 -8.80 -7.00 85 416 24 -1.80 -19 62
Net Cash From Continuing Investing Activities
195 58 55 -8.80 -7.00 85 416 24 -1.80 -19 62
Purchase of Property, Plant & Equipment
-1.30 -1.60 -1.70 -2.40 -1.90 -2.00 -2.50 -4.00 -1.80 -3.10 -0.70
Acquisitions
-34 - -1.70 36 -30 - -93 - -0.40 -24 -23
Purchase of Investments
-88 -15 -7.60 -156 -2.00 -5.00 -31 -124 -2.10 -1.20 -1.50
Sale and/or Maturity of Investments
216 41 169 25 12 2.00 632 -587 2.50 9.30 91
Net Cash From Financing Activities
-26 -240 92 -8.40 -7.40 -122 -228 -92 -23 -39 -51
Net Cash From Continuing Financing Activities
-26 -240 92 -8.40 -7.40 -122 -228 -92 -23 -39 -51
Repayment of Debt
-26 -1.60 -0.40 -0.80 -0.50 - -141 -0.70 -0.70 -1.70 -0.30
Repurchase of Common Equity
- -231 0.20 -0.20 0.00 - -120 -87 -15 -32 -46
Payment of Dividends
0.00 - -7.50 -7.70 -7.60 -7.80 -8.00 -7.10 -6.90 -6.60 -6.30
Issuance of Debt
0.30 0.10 103 0.50 2.30 -1.70 42 2.80 0.20 1.30 1.10
Other Financing Activities, net
-0.60 - -2.80 -0.20 -1.60 - - - -1.20 -0.10 -0.20

Annual Balance Sheets for Cannae

This table presents Cannae's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,473 1,487 1,460 2,092 4,613 3,890 3,126 2,687 2,229 1,309
Total Current Assets
273 350 452 631 844 122 311 177 197 257
Cash & Equivalents
142 246 316 534 725 86 248 106 132 180
Current Deferred & Refundable Income Taxes
- - - - - 0.00 1.90 26 36 49
Other Current Assets
- - - 97 84 36 26 30 24 20
Other Current Nonoperating Assets
22 - 30 - - - - - - 7.40
Plant, Property, & Equipment, net
235 219 176 163 146 101 88 59 62 43
Total Noncurrent Assets
966 918 832 1,299 3,623 3,667 2,727 2,451 1,970 1,009
Long-Term Investments
476 490 463 922 1,517 2,370 2,087 1,864 944 818
Noncurrent Note & Lease Receivables
- - - 193 202 172 156 144 136 79
Goodwill
103 203 77 66 53 53 53 53 53 53
Intangible Assets
112 215 92 63 52 27 24 17 15 9.80
Noncurrent Deferred & Refundable Income Taxes
33 11 24 55 - 0.00 23 82 74 0.60
Other Noncurrent Operating Assets
- - - 0.00 1,799 1,045 385 291 56 1.40
Other Noncurrent Nonoperating Assets
242 - 176 - - - - - 692 47
Total Liabilities & Shareholders' Equity
1,473 1,487 1,460 2,092 4,613 3,890 3,126 2,687 2,229 1,309
Total Liabilities
464 334 260 562 828 549 411 378 414 330
Total Current Liabilities
160 250 160 199 202 180 123 108 147 130
Short-Term Debt
11 122 5.90 7.00 11 2.30 2.30 2.50 61 1.40
Accounts Payable
92 101 96 86 93 106 79 74 55 81
Current Deferred Revenue
25 26 26 26 24 23 19 17 16 9.00
Other Current Liabilities
- - - 42 26 24 23 14 15 11
Other Current Nonoperating Liabilities
32 - 8.40 - - - - - - 27
Total Noncurrent Liabilities
304 84 100 364 626 369 288 270 267 200
Long-Term Debt
93 13 42 120 52 14 95 103 120 65
Noncurrent Deferred & Payable Income Tax Liabilities
- - - 0.00 325 144 - - - 0.00
Other Noncurrent Operating Liabilities
61 63 57 244 249 211 193 168 147 88
Other Noncurrent Nonoperating Liabilities
150 - 0.50 - - - - - - 47
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,010 1,153 1,200 1,530 3,785 3,341 2,715 2,309 1,815 979
Total Preferred & Common Equity
894 1,059 1,125 1,489 3,780 3,335 2,719 2,325 1,837 1,012
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
894 1,059 1,125 1,489 3,780 3,335 2,719 2,325 1,837 1,012
Common Stock
0.00 1,130 1,146 1,397 1,876 1,888 1,936 1,977 2,013 2,041
Retained Earnings
0.00 0.20 46 144 1,930 1,643 1,215 901 567 12
Treasury Stock
- 0.00 -0.20 -5.90 -21 -189 -414 -534 -725 -1,047
Accumulated Other Comprehensive Income / (Loss)
-68 -71 -67 -46 -4.90 -7.20 -18 -20 -19 6.50
Noncontrolling Interest
116 94 75 41 5.60 5.80 -3.90 -15 -21 -33

Quarterly Balance Sheets for Cannae

This table presents Cannae's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
2,996 2,768 2,610 2,224 2,286 2,096 1,786 1,514 1,240 1,258 1,113
Total Current Assets
190 126 336 101 215 774 624 265 209 191 156
Cash & Equivalents
113 58 238 46 161 126 67 234 136 70 112
Current Deferred & Refundable Income Taxes
0.00 4.50 25 25 26 11 11 13 48 47 1.50
Other Current Assets
24 45 26 21 20 20 18 19 25 36 42
Other Current Nonoperating Assets
- - - - - 617 528 - - 37 0.00
Plant, Property, & Equipment, net
79 63 57 64 63 54 53 52 45 43 54
Total Noncurrent Assets
2,727 2,579 2,217 2,059 2,008 1,269 1,109 1,197 986 1,025 903
Long-Term Investments
2,119 2,025 1,824 1,661 1,643 964 816 913 810 785 720
Noncurrent Note & Lease Receivables
150 123 141 140 138 135 132 129 109 96 72
Goodwill
53 53 53 53 53 53 53 53 53 21 5.10
Intangible Assets
22 22 16 16 15 15 14 14 13 11 8.50
Noncurrent Deferred & Refundable Income Taxes
48 85 29 63 69 55 55 50 1.00 1.00 0.00
Other Noncurrent Operating Assets
335 271 153 126 90 48 39 38 1.10 111 98
Other Noncurrent Nonoperating Assets
- - - - - 0.00 0.00 0.00 - - 0.00
Total Liabilities & Shareholders' Equity
2,996 2,768 2,610 2,224 2,286 2,096 1,786 1,514 1,240 1,258 1,113
Total Liabilities
414 403 345 341 423 400 429 332 317 347 230
Total Current Liabilities
128 118 101 99 84 185 225 131 122 154 81
Short-Term Debt
5.00 3.10 1.90 0.50 1.90 102 107 6.90 5.80 5.40 1.00
Accounts Payable
87 88 70 70 56 54 89 97 87 88 56
Current Deferred Revenue
14 12 15 14 12 14 13 12 15 20 13
Other Current Liabilities
21 16 14 14 14 15 15 15 16 16 11
Other Current Nonoperating Liabilities
- - - - - - - - - 26 0.00
Total Noncurrent Liabilities
286 284 244 241 339 215 205 201 195 193 149
Long-Term Debt
98 100 77 78 179 69 62 62 65 65 65
Noncurrent Deferred & Payable Income Tax Liabilities
- - - - - - - - - 1.90 2.20
Other Noncurrent Operating Liabilities
187 185 166 164 160 147 143 139 130 127 82
Other Noncurrent Nonoperating Liabilities
- - - - - - - - - - 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,582 2,366 2,265 1,884 1,863 1,697 1,357 1,183 922 912 883
Total Preferred & Common Equity
2,592 2,389 2,282 1,901 1,884 1,720 1,381 1,210 959 958 885
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
2,592 2,389 2,282 1,901 1,884 1,720 1,381 1,210 959 958 885
Common Stock
1,957 1,966 1,985 1,998 2,005 2,021 2,035 2,038 2,044 2,047 2,050
Retained Earnings
1,123 966 805 642 621 447 200 124 -28 3.40 -22
Treasury Stock
-475 -527 -491 -722 -725 -726 -839 -960 -1,063 -1,093 -1,141
Accumulated Other Comprehensive Income / (Loss)
-14 -16 -17 -18 -17 -21 -16 8.80 6.00 0.00 -1.70
Noncontrolling Interest
-10 -23 -17 -17 -21 -23 -25 -27 -37 -46 -2.20

Annual Metrics And Ratios for Cannae

This table displays calculated financial ratios and metrics derived from Cannae's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 49,285,406.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 49,285,406.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -20.83
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% -16.70% -1.85% -0.79% -6.75% -45.26% 26.72% -10.79% -13.91% -20.61% -6.39%
EBITDA Growth
0.00% 7.36% -120.71% 667.59% 305.10% 568.72% -117.73% 28.86% 41.50% -39.27% 25.42%
EBIT Growth
0.00% 2,466.67% -1,122.54% 128.93% 1,043.33% 805.33% -120.44% 26.67% 37.75% -26.68% 22.85%
NOPAT Growth
0.00% 22.08% -721.97% 9.62% -115.45% -39.09% 36.40% -8.31% 17.77% 12.78% -15.33%
Net Income Growth
0.00% -63.01% 877.31% -111.46% 541.51% 3,660.26% -116.27% -50.00% 24.56% 4.32% -69.27%
EPS Growth
0.00% 43.75% 955.56% -74.68% 174.36% 1,842.99% -115.34% -64.58% 18.67% -10.77% -91.97%
Operating Cash Flow Growth
0.00% 443.24% -250.41% 74.75% -267.69% -35.27% -54.61% -16.47% 57.19% -2.62% 79.91%
Free Cash Flow Firm Growth
0.00% 0.00% 39.19% 208.90% -127.15% -2,181.17% 138.01% -37.99% -119.22% 293.09% -32.73%
Invested Capital Growth
0.00% 0.00% 46.99% -55.04% -16.28% 681.70% -42.64% -50.89% -3.27% -47.93% -77.58%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -3.79% 1.83% -15.58% 1.57% -3.81% -6.00% -2.04% -1.53%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 291.90% 54.14% 27.72% -213.20% 41.98% -79.39% -33.82% 13.39%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 154.12% 49.88% 29.39% -249.80% 38.56% -52.25% -28.64% 11.70%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 39.93% -37.37% 3.40% 13.38% 9.85% -3.48% 2.54% -1.79%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 75.23% -28.88% 42.10% -181.13% 24.71% -35.78% 3.24% -11.18%
EPS Q/Q Growth
0.00% 0.00% 0.00% 230.00% -23.57% 31.42% -195.51% 19.97% -29.39% 2.67% -17.31%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -36.80% 18.51% -537.88% 51.74% -172.60% 7.32% -20.60% 19.12% 60.74%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -161.21% -26.84% 3,571.50% -53.81% -131.18% 120.38% 99.96%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -57.75% -47.48% 10.13% -30.84% 6.14% 16.86% -3.80% -52.34%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
9.48% 10.69% 14.32% 13.61% 14.69% 10.48% 6.02% 4.71% 7.54% 0.64% -1.94%
EBITDA Margin
4.61% 5.94% -1.25% 7.17% 31.16% 380.66% -53.26% -42.47% -28.86% -50.63% -38.17%
Operating Margin
-0.86% -0.19% -6.70% -12.71% -10.99% -32.18% -17.99% -21.84% -20.86% -22.92% -28.23%
EBIT Margin
-0.02% 0.60% -6.28% 1.83% 22.44% 371.13% -59.86% -49.21% -35.58% -56.77% -44.55%
Profit (Net Income) Margin
-0.52% -1.01% 8.00% -0.92% 4.37% 300.46% -38.59% -64.88% -56.86% -68.53% -123.91%
Tax Burden Percent
192.11% -228.85% -124.50% -46.90% 19.67% 80.65% 66.14% 128.01% 156.49% 117.51% 275.54%
Interest Burden Percent
1,266.67% 73.24% 102.34% 107.62% 99.08% 100.38% 97.46% 103.01% 102.12% 102.72% 100.95%
Effective Tax Rate
0.00% -200.00% 0.00% 66.37% 10.17% 22.05% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -3.63% -12.09% -12.66% -47.88% -16.57% -7.56% -15.06% -19.11% -22.29% -61.33%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -1.99% -35.28% -17.53% -61.20% -124.24% 0.74% -1.12% -7.51% -8.61% -26.34%
Return on Net Nonoperating Assets (RNNOA)
0.00% 1.27% 20.64% 11.76% 51.30% 82.79% -0.48% 0.87% 6.21% 7.25% 23.77%
Return on Equity (ROE)
0.00% -2.36% 8.55% -0.90% 3.43% 66.22% -8.04% -14.19% -12.90% -15.04% -37.57%
Cash Return on Invested Capital (CROIC)
0.00% -203.63% -50.13% 63.28% -30.16% -171.21% 46.64% 53.21% -15.78% 40.75% 65.41%
Operating Return on Assets (OROA)
0.00% 0.48% -4.90% 1.43% 13.52% 64.83% -10.45% -9.29% -6.98% -10.45% -10.67%
Return on Assets (ROA)
0.00% -0.81% 6.25% -0.72% 2.64% 52.49% -6.74% -12.25% -11.15% -12.62% -29.67%
Return on Common Equity (ROCE)
0.00% -2.09% 7.72% -0.84% 3.28% 65.64% -8.03% -14.18% -12.95% -15.17% -38.30%
Return on Equity Simple (ROE_SIMPLE)
0.00% -1.33% 8.73% -0.94% 3.14% 46.56% -8.59% -15.80% -13.94% -16.89% 0.00%
Net Operating Profit after Tax (NOPAT)
-8.47 -6.60 -54 -49 -106 -147 -93 -101 -83 -73 -84
NOPAT Margin
-0.60% -0.56% -4.69% -4.27% -9.87% -25.09% -12.59% -15.29% -14.60% -16.04% -19.76%
Net Nonoperating Expense Percent (NNEP)
0.00% -1.64% 23.20% 4.87% 13.32% 107.67% -8.29% -13.94% -11.60% -13.68% -34.99%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -3.60% -3.45% -3.64% -7.97%
Cost of Revenue to Revenue
90.52% 89.31% 85.68% 86.39% 85.31% 89.52% 93.98% 95.29% 92.46% 99.36% 101.94%
SG&A Expenses to Revenue
6.81% 7.09% 8.76% 8.00% 12.47% 19.91% 20.43% 23.11% 25.07% 20.62% 23.49%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.33% 10.88% 21.02% 26.32% 25.68% 42.67% 24.01% 26.55% 28.40% 23.56% 26.30%
Earnings before Interest and Taxes (EBIT)
-0.30 7.10 -73 21 240 2,174 -444 -326 -203 -257 -189
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
65 70 -15 82 333 2,230 -395 -281 -165 -229 -162
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 1.13 1.09 1.79 1.07 0.93 0.58 0.58 0.68 0.76
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.86 1.28 1.96 1.10 0.95 0.60 0.60 0.70 0.81
Price to Revenue (P/Rev)
0.00 0.00 1.03 1.06 2.49 6.88 4.18 2.39 2.38 2.75 1.81
Price to Earnings (P/E)
0.00 0.00 10.97 44.27 34.43 2.26 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.81% 3.48%
Earnings Yield
0.00% 0.00% 9.12% 2.26% 2.90% 44.32% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.25 2.23 6.83 1.16 0.74 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.58 0.47 1.28 3.11 0.90 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 6.50 4.12 0.82 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 25.47 5.72 0.84 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 2.18 0.00 0.00 1.16 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.10 0.12 0.04 0.08 0.02 0.00 0.04 0.05 0.10 0.07
Long-Term Debt to Equity
0.00 0.09 0.01 0.04 0.08 0.01 0.00 0.04 0.04 0.07 0.07
Financial Leverage
0.00 -0.64 -0.58 -0.67 -0.84 -0.67 -0.65 -0.78 -0.83 -0.84 -0.90
Leverage Ratio
0.00 1.46 1.37 1.25 1.30 1.26 1.19 1.16 1.16 1.19 1.27
Compound Leverage Factor
0.00 1.07 1.40 1.35 1.29 1.27 1.16 1.19 1.18 1.22 1.28
Debt to Total Capital
0.00% 9.39% 10.47% 3.85% 7.67% 1.65% 0.49% 3.46% 4.35% 9.07% 6.74%
Short-Term Debt to Total Capital
0.00% 1.02% 9.49% 0.47% 0.42% 0.29% 0.07% 0.08% 0.10% 3.06% 0.60%
Long-Term Debt to Total Capital
0.00% 8.37% 0.99% 3.38% 7.25% 1.36% 0.42% 3.38% 4.25% 6.01% 6.14%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 10.44% 7.27% 6.02% 2.49% 0.15% 0.17% -0.14% -0.63% -1.06% -3.13%
Common Equity to Total Capital
0.00% 80.17% 82.25% 90.13% 89.84% 98.20% 99.34% 96.68% 96.28% 92.00% 96.39%
Debt to EBITDA
0.00 1.50 -9.30 0.58 0.38 0.03 -0.04 -0.35 -0.64 -0.79 -0.44
Net Debt to EBITDA
0.00 -8.07 42.68 -9.26 -3.99 -0.99 6.17 8.08 11.43 6.95 5.75
Long-Term Debt to EBITDA
0.00 1.33 -0.88 0.51 0.36 0.02 -0.04 -0.34 -0.62 -0.52 -0.40
Debt to NOPAT
0.00 -15.86 -2.49 -0.98 -1.20 -0.43 -0.18 -0.96 -1.26 -2.49 -0.85
Net Debt to NOPAT
0.00 85.55 11.41 15.55 12.58 15.06 26.10 22.45 22.60 21.94 11.10
Long-Term Debt to NOPAT
0.00 -14.14 -0.23 -0.86 -1.14 -0.36 -0.15 -0.94 -1.23 -1.65 -0.77
Altman Z-Score
0.00 0.00 2.84 3.94 4.07 5.35 3.78 2.79 2.62 2.01 1.37
Noncontrolling Interest Sharing Ratio
0.00% 11.52% 9.71% 7.17% 4.26% 0.88% 0.16% 0.03% -0.38% -0.89% -1.94%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.00 1.71 1.40 2.82 3.18 4.18 0.68 2.53 1.65 1.34 1.98
Quick Ratio
0.00 1.37 1.20 2.36 2.69 3.76 0.48 2.30 1.13 0.94 1.40
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -370 -225 245 -67 -1,518 577 358 -69 133 89
Operating Cash Flow to CapEx
0.00% 121.57% -226.18% -208.18% -1,220.29% -636.31% -5,336.36% -4,021.57% -3,251.85% -45,050.00% -208.05%
Free Cash Flow to Firm to Interest Expense
0.00 -71.17 -32.15 52.14 -3.74 -168.65 58.86 29.08 -3.84 11.44 7.50
Operating Cash Flow to Interest Expense
2.02 11.60 -12.96 -4.87 -4.73 -12.66 -17.97 -16.67 -4.91 -7.77 -1.52
Operating Cash Flow Less CapEx to Interest Expense
6.89 2.06 -18.69 -7.21 -5.12 -14.64 -18.31 -17.09 -5.06 -7.78 -2.25
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.80 0.78 0.78 0.60 0.17 0.17 0.19 0.20 0.18 0.24
Accounts Receivable Turnover
0.00 47.71 38.23 34.67 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 44.03 36.98 38.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 5.01 5.10 5.82 6.33 3.80 6.02 7.04 7.80 7.51 7.65
Accounts Payable Turnover
0.00 11.50 10.31 10.10 10.03 5.84 7.02 6.84 6.88 6.97 5.89
Days Sales Outstanding (DSO)
0.00 7.65 9.55 10.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 8.29 9.87 9.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 31.73 35.40 36.14 36.39 62.52 52.02 53.40 53.05 52.36 62.00
Cash Conversion Cycle (CCC)
0.00 -15.79 -15.98 -16.04 -36.39 -62.52 -52.02 -53.40 -53.05 -52.36 -62.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.00 364 534 240 201 1,572 902 443 428 223 50
Invested Capital Turnover
0.00 6.48 2.58 2.96 4.85 0.66 0.60 0.98 1.31 1.39 3.10
Increase / (Decrease) in Invested Capital
0.00 364 171 -294 -39 1,371 -670 -459 -15 -205 -173
Enterprise Value (EV)
0.00 0.00 669 535 1,374 1,822 670 -695 -542 -367 -197
Market Capitalization
0.00 0.00 1,194 1,222 2,661 4,030 3,104 1,581 1,354 1,246 765
Book Value per Share
$0.00 $12.66 $15.01 $15.65 $20.66 $41.24 $37.51 $34.85 $32.87 $29.27 $20.53
Tangible Book Value per Share
$0.00 $9.61 $9.10 $13.30 $18.87 $40.09 $36.61 $33.86 $31.88 $28.18 $19.18
Total Capital
0.00 1,115 1,288 1,248 1,657 3,849 3,358 2,812 2,414 1,996 1,050
Total Debt
0.00 105 135 48 127 64 16 97 105 181 71
Total Long-Term Debt
0.00 93 13 42 120 52 14 95 103 120 65
Net Debt
0.00 -565 -619 -762 -1,329 -2,213 -2,439 -2,272 -1,881 -1,592 -929
Capital Expenditures (CapEx)
-27 50 40 11 6.90 18 3.30 5.10 2.70 0.20 8.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -69 -41 -50 -95 -106 -141 -92 -50 -26 -49
Debt-free Net Working Capital (DFNWC)
0.00 125 223 298 439 654 -56 190 72 111 133
Net Working Capital (NWC)
0.00 113 100 292 432 642 -58 188 70 50 127
Net Nonoperating Expense (NNE)
-1.17 5.30 -147 -38 -152 -1,907 193 328 241 238 441
Net Nonoperating Obligations (NNO)
0.00 -646 -619 -960 -1,329 -2,213 -2,439 -2,272 -1,881 -1,592 -929
Total Depreciation and Amortization (D&A)
66 63 58 61 93 56 49 45 38 28 27
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -5.86% -3.52% -4.31% -8.83% -18.17% -19.05% -13.96% -8.68% -5.81% -11.54%
Debt-free Net Working Capital to Revenue
0.00% 10.57% 19.25% 25.93% 41.05% 111.58% -7.49% 28.73% 12.68% 24.62% 31.42%
Net Working Capital to Revenue
0.00% 9.60% 8.68% 25.42% 40.39% 109.65% -7.80% 28.38% 12.25% 11.14% 29.93%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.32) ($0.18) $1.54 $0.39 $1.07 $20.84 ($3.19) ($5.25) ($4.27) ($4.73) ($9.08)
Adjusted Weighted Average Basic Shares Outstanding
70.60M 70.60M 70.60M 71.20M 72.20M 85.70M 90.10M 81.60M 73.40M 64.40M 56.50M
Adjusted Diluted Earnings per Share
($0.32) ($0.18) $1.54 $0.39 $1.07 $20.79 ($3.19) ($5.25) ($4.27) ($4.73) ($9.08)
Adjusted Weighted Average Diluted Shares Outstanding
70.60M 70.60M 70.60M 71.30M 72.40M 85.90M 90.10M 81.60M 73.40M 64.40M 56.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 68.90M 70.86M 72.22M 79.52M 91.65M 86.49M 76.26M 72.48M 62.79M 46.32M
Normalized Net Operating Profit after Tax (NOPAT)
-8.47 -1.54 -54 -83 -96 -141 -93 -101 -83 -73 -84
Normalized NOPAT Margin
-0.60% -0.13% -4.69% -7.27% -9.00% -24.05% -12.59% -15.29% -14.60% -16.04% -19.76%
Pre Tax Income Margin
-0.27% 0.44% -6.42% 1.97% 22.23% 372.53% -58.34% -50.69% -36.33% -58.32% -44.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.05 1.37 -10.37 4.47 13.49 241.52 -45.34 -26.49 -11.33 -22.15 -15.86
NOPAT to Interest Expense
-1.54 -1.27 -7.75 -10.43 -5.93 -16.33 -9.54 -8.23 -4.65 -6.26 -7.04
EBIT Less CapEx to Interest Expense
4.82 -8.17 -16.10 2.13 13.10 239.53 -45.67 -26.90 -11.48 -22.16 -16.59
NOPAT Less CapEx to Interest Expense
3.33 -10.81 -13.48 -12.77 -6.32 -18.31 -9.87 -8.64 -4.80 -6.28 -7.77
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-376.71% -5.88% 0.43% -0.94% 1.92% 0.05% -0.07% -1.89% -0.22% -7.32% -5.81%
Augmented Payout Ratio
-376.71% -5.88% 0.43% -0.94% 12.39% 0.86% -56.01% -55.31% -35.14% -81.94% -66.72%

Quarterly Metrics And Ratios for Cannae

This table displays calculated financial ratios and metrics derived from Cannae's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - 49,285,406.00 46,324,719.00 43,940,506.00 43,374,227.00
DEI Adjusted Shares Outstanding
- - - - - - - 49,285,406.00 46,324,719.00 43,940,506.00 43,374,227.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - -12.30 -1.39 1.71 -0.93
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-28.26% -22.77% -20.68% -7.88% -6.78% -6.61% -6.15% -6.01% -6.78% -7.26% -16.24%
EBITDA Growth
-173.60% -208.02% 106.97% -279.71% 73.45% 19.42% -88.89% 34.05% -205.19% 123.80% -13.46%
EBIT Growth
-221.43% -172.01% 102.90% -465.04% 60.22% 18.83% -202.00% 28.22% -106.34% 118.96% 254.55%
NOPAT Growth
-38.12% -17.35% -46.35% 72.90% 47.29% -164.78% 84.08% -9.55% -3.27% -25.24% -231.87%
Net Income Growth
-1,230.43% -71.46% 89.74% 18.51% -25.27% -55.16% -304.57% -115.28% 68.87% 111.81% 65.25%
EPS Growth
-2,440.00% -114.66% 89.91% 14.77% -42.52% -57.83% -468.18% -178.67% 61.33% 121.88% 61.60%
Operating Cash Flow Growth
-82.74% 31.54% -60.30% 63.96% 125.28% -111.76% 32.29% 233.33% -332.97% 75.93% 223.01%
Free Cash Flow Firm Growth
-21.79% 42.05% 467.37% 548.63% -61.42% -35.41% 53.49% -17.78% 60.29% -160.61% -124.15%
Invested Capital Growth
-44.05% -38.48% -36.75% -47.93% -32.08% -53.49% -54.75% -77.58% -70.37% 0.52% 11.63%
Revenue Q/Q Growth
-7.21% 6.59% -3.47% -3.51% -6.10% 6.78% -2.99% -3.37% -6.87% 6.24% -33.37%
EBITDA Q/Q Growth
-240.10% -279.76% 107.43% -410.00% 79.30% -1,597.40% 100.99% -1,992.31% 4.47% 232.34% -85.53%
EBIT Q/Q Growth
-390.24% -241.67% 103.15% -947.17% 68.37% -865.49% 96.28% -533.33% 9.29% 188.74% -85.00%
NOPAT Q/Q Growth
49.99% 43.35% -230.24% 71.04% 2.73% -184.58% 78.33% -82.58% 8.30% -245.11% 67.80%
Net Income Q/Q Growth
-63.35% -68.85% 88.71% -161.71% -151.09% -109.13% 70.56% -39.27% 63.69% 179.33% -186.62%
EPS Q/Q Growth
-44.32% -96.06% 91.16% -240.91% -141.33% -117.13% 68.19% -67.20% 66.51% 222.86% -155.81%
Operating Cash Flow Q/Q Growth
-8.11% 71.67% -212.75% 62.38% 175.83% -337.36% 0.00% 174.07% -232.50% 75.47% 665.38%
Free Cash Flow Firm Q/Q Growth
471.81% -12.38% -40.88% 132.92% -68.03% 46.69% 32.10% 32.70% -37.66% -155.47% 45.56%
Invested Capital Q/Q Growth
-44.90% 4.32% -5.85% -3.80% -28.12% -28.57% -8.38% -52.34% -5.00% 142.32% 1.74%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
-6.05% 5.68% 2.46% 0.09% -1.94% -15.25% 5.80% 4.26% 1.14% 3.91% 1.03%
EBITDA Margin
-26.20% -136.78% 10.54% -33.85% -7.46% -118.60% 1.22% -23.81% -24.43% 30.43% 6.61%
Operating Margin
-36.68% -19.49% -15.89% -20.02% -20.74% -55.26% -12.35% -23.33% -22.97% -55.58% -38.77%
EBIT Margin
-32.25% -142.46% 4.65% -40.86% -13.76% -124.41% -4.77% -31.27% -30.46% 25.44% 5.73%
Profit (Net Income) Margin
-82.93% -131.36% -15.36% -41.67% -111.43% -218.24% -66.23% -95.45% -37.21% 27.79% -36.12%
Tax Burden Percent
253.59% 91.50% -546.88% 95.42% 692.77% 177.36% 1,089.23% 310.06% 121.36% 100.35% -572.09%
Interest Burden Percent
101.40% 100.77% 60.38% 106.90% 116.90% 98.91% 127.45% 98.45% 100.68% 108.85% 110.26%
Effective Tax Rate
0.00% 0.00% -193.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.01% 34.88%
Return on Invested Capital (ROIC)
-41.09% -20.75% -72.08% -19.47% -32.60% -93.78% -22.09% -50.68% -64.48% -185.93% -89.92%
ROIC Less NNEP Spread (ROIC-NNEP)
-38.16% -13.48% -74.04% -17.72% -26.99% -80.03% -17.54% -44.20% -62.79% -193.95% -89.12%
Return on Net Nonoperating Assets (RNNOA)
33.12% 11.53% 63.56% 14.92% 24.29% 71.12% 15.60% 39.88% 57.81% 174.32% 79.54%
Return on Equity (ROE)
-7.97% -9.23% -8.51% -4.55% -8.31% -22.65% -6.48% -10.80% -6.67% -11.61% -10.38%
Cash Return on Invested Capital (CROIC)
27.38% 17.28% 20.13% 40.75% 8.35% 25.52% 26.52% 65.41% 27.52% -71.38% -96.25%
Operating Return on Assets (OROA)
-5.91% -26.83% 0.85% -7.52% -2.60% -27.13% -1.08% -7.49% -7.61% 6.83% 1.72%
Return on Assets (ROA)
-15.20% -24.74% -2.81% -7.67% -21.07% -47.59% -14.99% -22.86% -9.29% 7.46% -10.87%
Return on Common Equity (ROCE)
-8.01% -9.28% -8.60% -4.59% -8.39% -22.95% -6.59% -11.01% -6.82% -11.97% -10.53%
Return on Equity Simple (ROE_SIMPLE)
-17.92% -24.92% -17.01% 0.00% -19.38% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-28 -16 -53 -15 -15 -43 -9.24 -17 -15 -53 -17
NOPAT Margin
-25.67% -13.64% -46.68% -14.01% -14.52% -38.68% -8.64% -16.33% -16.08% -52.24% -25.24%
Net Nonoperating Expense Percent (NNEP)
-2.93% -7.27% 1.97% -1.75% -5.61% -13.74% -4.55% -6.48% -1.69% 8.02% -0.80%
Return On Investment Capital (ROIC_SIMPLE)
-1.21% - - -0.77% -0.80% -2.80% -0.74% -1.61% -1.56% -5.44% -1.81%
Cost of Revenue to Revenue
106.05% 94.32% 97.54% 99.91% 101.94% 115.25% 94.20% 95.74% 98.86% 96.09% 98.97%
SG&A Expenses to Revenue
27.64% 22.29% 15.45% 17.11% 15.79% 37.30% 15.44% 24.78% 21.41% 25.73% 14.10%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
30.62% 25.17% 18.35% 20.11% 18.80% 40.02% 18.15% 27.59% 24.12% 59.49% 39.79%
Earnings before Interest and Taxes (EBIT)
-36 -168 5.30 -45 -14 -137 -5.10 -32 -29 26 3.90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-29 -161 12 -37 -7.70 -131 1.30 -25 -24 31 4.50
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.69 0.60 0.63 0.68 0.67 0.95 0.85 0.76 0.55 0.66 0.75
Price to Tangible Book Value (P/TBV)
0.71 0.62 0.66 0.70 0.70 1.00 0.90 0.81 0.59 0.68 0.76
Price to Revenue (P/Rev)
2.98 2.32 2.59 2.75 2.59 3.00 2.38 1.81 1.26 1.55 1.68
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.66% 1.26% 1.81% 2.62% 2.30% 2.79% 3.48% 5.01% 4.17% 3.91%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 1.30 4.99 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.47 1.31 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 12.61 12.40 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.04 0.04 0.10 0.10 0.10 0.12 0.06 0.07 0.08 0.08 0.07
Long-Term Debt to Equity
0.03 0.04 0.10 0.07 0.04 0.05 0.05 0.07 0.07 0.07 0.07
Financial Leverage
-0.87 -0.86 -0.86 -0.84 -0.90 -0.89 -0.89 -0.90 -0.92 -0.90 -0.89
Leverage Ratio
1.15 1.17 1.20 1.19 1.19 1.24 1.25 1.27 1.27 1.34 1.27
Compound Leverage Factor
1.17 1.18 0.72 1.27 1.39 1.22 1.59 1.25 1.28 1.46 1.40
Debt to Total Capital
3.38% 3.99% 8.87% 9.07% 9.14% 11.04% 5.48% 6.74% 7.08% 7.12% 6.92%
Short-Term Debt to Total Capital
0.08% 0.03% 0.09% 3.06% 5.46% 7.00% 0.55% 0.60% 0.58% 0.55% 0.11%
Long-Term Debt to Total Capital
3.30% 3.96% 8.77% 6.01% 3.67% 4.05% 4.93% 6.14% 6.50% 6.57% 6.81%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-0.73% -0.88% -1.04% -1.06% -1.24% -1.62% -2.17% -3.13% -3.68% -4.65% -0.23%
Common Equity to Total Capital
97.35% 96.89% 92.17% 92.00% 92.11% 90.58% 96.69% 96.39% 96.60% 97.54% 93.32%
Debt to EBITDA
-0.34 -0.22 -1.06 -0.79 -0.82 -0.96 -0.37 -0.44 -0.40 -4.45 -4.00
Net Debt to EBITDA
8.71 4.61 9.53 6.95 4.42 4.05 5.77 5.75 4.93 50.01 46.70
Long-Term Debt to EBITDA
-0.33 -0.22 -1.05 -0.52 -0.33 -0.35 -0.33 -0.40 -0.36 -4.11 -3.94
Debt to NOPAT
-0.83 -0.80 -2.43 -2.49 -2.88 -1.97 -0.83 -0.85 -0.83 -0.86 -0.69
Net Debt to NOPAT
21.19 16.68 21.90 21.94 15.54 8.34 13.10 11.10 10.39 9.65 8.09
Long-Term Debt to NOPAT
-0.81 -0.79 -2.41 -1.65 -1.16 -0.72 -0.75 -0.77 -0.77 -0.79 -0.68
Altman Z-Score
3.43 2.38 2.35 2.33 2.55 2.25 2.35 1.76 1.31 1.53 2.16
Noncontrolling Interest Sharing Ratio
-0.48% -0.61% -1.05% -0.89% -1.02% -1.29% -1.59% -1.94% -2.28% -3.10% -1.42%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.32 1.01 2.55 1.34 4.19 2.78 2.03 1.98 1.71 1.24 1.93
Quick Ratio
2.81 0.55 2.01 0.94 0.68 0.30 1.79 1.40 1.11 0.46 1.38
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
157 138 82 190 61 89 118 156 97 -54 -29
Operating Cash Flow to CapEx
-12,000.00% 0.00% 0.00% -521.74% 4,550.00% -1,080.00% -864.00% 400.00% -1,177.78% -167.74% 4,200.00%
Free Cash Flow to Firm to Interest Expense
60.53 68.95 28.11 46.32 15.98 26.99 35.65 104.09 42.32 -44.99 -32.66
Operating Cash Flow to Interest Expense
-13.85 -5.10 -11.00 -2.93 2.39 -6.55 -6.55 10.67 -9.22 -4.33 32.67
Operating Cash Flow Less CapEx to Interest Expense
-13.96 -4.70 -10.45 -3.49 2.34 -7.15 -7.30 8.00 -10.00 -6.92 31.89
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.18 0.19 0.18 0.18 0.19 0.22 0.23 0.24 0.25 0.27 0.30
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
7.41 6.88 7.31 7.51 8.03 7.45 7.47 7.65 8.49 8.54 7.44
Accounts Payable Turnover
6.75 5.96 6.23 6.97 7.08 5.67 5.80 5.89 6.02 4.44 5.07
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
54.07 61.22 58.59 52.36 51.57 64.36 62.91 62.00 60.59 82.26 71.96
Cash Conversion Cycle (CCC)
-54.07 -61.22 -58.59 -52.36 -51.57 -64.36 -62.91 -62.00 -60.59 -82.26 -71.96
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
236 246 232 223 160 115 105 50 48 115 117
Invested Capital Turnover
1.60 1.52 1.54 1.39 2.25 2.42 2.56 3.10 4.01 3.56 3.56
Increase / (Decrease) in Invested Capital
-186 -154 -135 -205 -76 -132 -127 -173 -113 0.60 12
Enterprise Value (EV)
-476 -516 -456 -367 209 571 -79 -197 -385 -198 -103
Market Capitalization
1,570 1,139 1,196 1,246 1,151 1,310 1,026 765 527 633 665
Book Value per Share
$31.49 $30.28 $30.03 $29.27 $27.39 $21.99 $21.60 $20.53 $20.70 $21.79 $20.41
Tangible Book Value per Share
$30.53 $29.18 $28.93 $28.18 $26.31 $20.92 $20.40 $19.18 $19.27 $21.05 $20.09
Total Capital
2,344 1,962 2,044 1,996 1,867 1,525 1,251 1,050 993 982 949
Total Debt
79 78 181 181 171 168 69 71 70 70 66
Total Long-Term Debt
77 78 179 120 69 62 62 65 65 65 65
Net Debt
-2,029 -1,637 -1,631 -1,592 -919 -714 -1,078 -929 -875 -785 -766
Capital Expenditures (CapEx)
0.30 -0.80 -1.60 2.30 0.20 2.00 2.50 4.00 1.80 3.10 0.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-48 -53 -37 -26 565 439 -92 -49 -44 -28 -36
Debt-free Net Working Capital (DFNWC)
236 1.90 133 111 691 506 141 133 92 43 76
Net Working Capital (NWC)
234 1.40 131 50 589 399 135 127 86 38 75
Net Nonoperating Expense (NNE)
63 139 -36 30 100 198 62 82 20 -82 7.41
Net Nonoperating Obligations (NNO)
-2,029 -1,637 -1,631 -1,592 -1,536 -1,242 -1,078 -929 -875 -797 -766
Total Depreciation and Amortization (D&A)
6.70 6.70 6.70 7.70 6.50 6.40 6.40 7.70 5.80 5.10 0.60
Debt-free, Cash-free Net Working Capital to Revenue
-9.08% -10.72% -8.03% -5.81% 126.90% 100.41% -21.48% -11.54% -10.47% -6.73% -9.05%
Debt-free Net Working Capital to Revenue
44.89% 0.39% 28.69% 24.62% 155.26% 115.67% 32.87% 31.42% 22.11% 10.50% 19.20%
Net Working Capital to Revenue
44.53% 0.28% 28.27% 11.14% 132.34% 91.26% 31.26% 29.93% 20.72% 9.18% 18.94%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.27) ($2.49) ($0.22) ($0.75) ($1.81) ($3.93) ($1.25) ($2.09) ($0.70) $0.86 ($0.48)
Adjusted Weighted Average Basic Shares Outstanding
70.80M 62.20M 62.40M 64.40M 62.30M 60.80M 54.70M 56.50M 45.90M 43.50M 42.30M
Adjusted Diluted Earnings per Share
($1.27) ($2.49) ($0.22) ($0.75) ($1.81) ($3.93) ($1.25) ($2.09) ($0.70) $0.86 ($0.48)
Adjusted Weighted Average Diluted Shares Outstanding
70.90M 62.20M 62.40M 64.40M 62.30M 60.80M 54.70M 56.50M 45.90M 43.60M 42.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
62.77M 62.73M 62.74M 62.79M 62.82M 56.01M 49.29M 46.32M 43.94M 43.37M 39.23M
Normalized Net Operating Profit after Tax (NOPAT)
-28 -16 -13 -15 -15 -43 -9.24 -17 -15 -23 -6.64
Normalized NOPAT Margin
-25.67% -13.64% -11.12% -14.01% -14.52% -38.68% -8.64% -16.33% -16.08% -22.72% -9.75%
Pre Tax Income Margin
-32.70% -143.56% 2.81% -43.68% -16.09% -123.05% -6.08% -30.78% -30.67% 27.69% 6.31%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-13.73 -84.05 1.83 -10.95 -3.74 -41.55 -1.55 -21.53 -12.74 21.67 4.33
NOPAT to Interest Expense
-10.93 -8.05 -18.33 -3.76 -3.94 -12.92 -2.80 -11.25 -6.73 -44.49 -19.10
EBIT Less CapEx to Interest Expense
-13.85 -83.65 2.38 -11.51 -3.79 -42.15 -2.30 -24.20 -13.52 19.08 3.56
NOPAT Less CapEx to Interest Expense
-11.05 -7.65 -17.78 -4.32 -3.99 -13.52 -3.56 -13.91 -7.51 -47.07 -19.88
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% -1.73% -4.87% -7.32% -9.09% -7.31% -6.59% -5.81% -6.69% -16.18% -20.60%
Augmented Payout Ratio
0.00% -62.86% -79.22% -81.94% -9.09% -34.26% -55.90% -66.72% -81.71% -159.67% -158.04%

Financials Breakdown Chart

Key Financial Trends

Cannae’s Q2 2026 results show a sharp improvement in reported net income, but underlying operating performance and cash generation remain weak. Revenue increased to $102.2 million from $96.2 million in Q1 2026, while gross profit improved to $4.0 million from $1.1 million. However, revenue remains below the $110.2 million reported in Q2 2025 and far below the $174.5 million reported in Q2 2022.

Operating profitability continues to be the central concern. Cannae posted a $56.8 million operating loss in Q2 2026, compared with operating losses of $22.1 million in Q1 2026 and $24.1 million in Q4 2025. The latest quarter included a $32.1 million impairment charge, while selling, general and administrative expense rose to $26.3 million from $20.6 million in Q1.

Reported consolidated net income was $28.4 million in Q2, compared with a $35.8 million loss in Q1 and a $98.6 million loss in Q4 2025. Much of the improvement came from $82.8 million of net other income and $1.8 million of other gains, rather than from the company’s core operations. The data also reports $75.0 million of net income attributable to common shareholders, a figure that does not reconcile conventionally with consolidated net income and the reported noncontrolling-interest amount. Investors should review the company’s filing for the detailed reconciliation.

Cash flow remains pressured. Operating cash flow was negative $5.2 million in Q2, following negative operating cash flow of $21.2 million in Q1 2026 and negative $21.6 million in Q2 2025. Cannae also spent $24.2 million on acquisitions and $3.1 million on property and equipment during the quarter. As a result, cash and equivalents fell to $70.4 million from $135.7 million at the end of Q1 and $233.8 million at the end of Q3 2025.

The balance sheet remains supported by a large investment portfolio and substantial equity, but the asset base has contracted considerably. Total assets declined to $1.26 billion in Q2 2026 from $2.10 billion in Q1 2025 and $2.29 billion in Q3 2024. Long-term investments totaled $784.6 million, while total debt was approximately $69.9 million, consisting of $5.4 million of short-term debt and $64.5 million of long-term debt.

  • Reported earnings rebounded: Consolidated net income improved to $28.4 million in Q2 2026 from losses in each of the previous three reported quarters.
  • Quarterly revenue and gross profit improved sequentially: Revenue rose 6.2% from Q1 2026, and gross profit increased from $1.1 million to $4.0 million.
  • Debt levels remain manageable: Total reported debt of approximately $69.9 million is modest relative to $911.9 million of total equity and $784.6 million of long-term investments.
  • Shareholder returns continued: Cannae repurchased $32.2 million of common stock and paid $6.6 million in dividends during Q2 2026.
  • Investment activity is driving liquidity changes: The company received $9.3 million from investment sales but spent $24.2 million on acquisitions, making quarterly cash trends dependent on portfolio transactions rather than operating cash flow.
  • Portfolio composition remains important: Long-term investments represented approximately 62% of total assets at quarter-end, leaving reported asset values and earnings sensitive to investment performance and valuation changes.
  • Operating losses persist: Cannae has reported negative operating income in every supplied quarter from Q1 2023 through Q2 2026.
  • Operating cash flow has generally been negative: Q2 2026 marked another quarter in which core operations failed to generate cash, despite the return to consolidated profitability.
  • Revenue has trended lower: Quarterly revenue declined from $174.5 million in Q2 2022 to $102.2 million in Q2 2026, indicating a substantially smaller operating base.
  • Cash reserves are shrinking: Cash declined by $63.7 million during Q2 2026, primarily because of negative operating and investing cash flow combined with buybacks and dividends.
11/19/26 12:38 AM ETAI Generated. May Contain Errors.

Cannae Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cannae's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Cannae's net income appears to be on a downward trend, with a most recent value of -$524.90 million in 2025, falling from -$7.30 million in 2015. The previous period was -$310.10 million in 2024. See Cannae's forecast for analyst expectations on what's next for the company.

Cannae's total operating income in 2025 was -$119.60 million, based on the following breakdown:
  • Total Gross Profit: -$8.20 million
  • Total Operating Expenses: $111.40 million

Over the last 10 years, Cannae's total revenue changed from $1.41 billion in 2015 to $423.60 million in 2025, a change of -70.1%.

In the past 13 quarters, Cannae's cash and equivalents has ranged from $45.70 million in Q2 2024 to $238.30 million in Q1 2024, and is currently $111.70 million as of their latest financial filing in Q3 2026.

Cannae had total debt of $70.80 million at the end of 2025, a 60.9% decrease from 2024, and none in 2015.

Over the last 10 years, Cannae's book value per share changed from 0.00 in 2015 to 20.53 in 2025, a change of 2,053.4%.



Financial statements for NYSE:CNNE last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners